Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1989 Jun;134(6):1315–1327.

Immunohistochemical analysis of LNT, NeuAc2----3LNT, and Lex carbohydrate antigens in human tumors and normal tissues.

P Garin-Chesa 1, W J Rettig 1
PMCID: PMC1879938  PMID: 2474254

Abstract

Monoclonal antibodies (MAbs) K21 and K4 define two carbohydrate determinants, lacto-N-tetraose (LNT) and sialylated LNT (NeuAc2----3LNT). respectively, which are expressed on the surface of cultured human teratocarcinoma cells, but not on a wide range of other epithelial and nonepithelial cells in culture. The present study used immunohistochemical methods to examine LNT and NeuAc2----3LNT expression in normal human tissues, 29 germ cell tumors, and over 200 tumors of other histologic types. In addition, their distribution was compared with that of Lex, a previously characterized cell surface carbohydrate antigen. Our results show that LNT and NeuAc2----3LNT are consistently expressed in germ cell tumors and that each has a distinct, highly restricted distribution in normal tissues. LNT and NeuAc2----3LNT expression in germ cell tumors is predominantly localized to embryonal carcinoma and yolk sac components, whereas Lex is found primarily in teratoma components with intestinal and bronchial differentiation. Areas of seminoma variably express NeuAc2----3LNT and LNT but are Lex-negative. Immunohistochemical results obtained with different fixation procedures suggest that some cell types in vivo express NeuAc2----3LNT, LNT, and Lex determinants only on glycolipids, whereas other express them on both glycolipids and glycoproteins or only on glycoproteins. Thus, the tissue distribution of these antigens may be controlled by differential expression of the requisite glycosyltransferases as well as the availability of different classes of carrier molecules.

Full text

PDF
1315

Images in this article

1324Figure 4
on p.1324
1318Figure 1
on p.1318
1321Figure 2
on p.1321
1323Figure 3
on p.1323

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981 Sep;127(3):1024–1029. [PubMed] [Google Scholar]
  2. Chou K. H., Ilyas A. A., Evans J. E., Quarles R. H., Jungalwala F. B. Structure of a glycolipid reacting with monoclonal IgM in neuropathy and with HNK-1. Biochem Biophys Res Commun. 1985 Apr 16;128(1):383–388. doi: 10.1016/0006-291x(85)91690-0. [DOI] [PubMed] [Google Scholar]
  3. Damjanov I., Fox N., Knowles B. B., Solter D., Lange P. H., Fraley E. E. Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors. Am J Pathol. 1982 Aug;108(2):225–230. [PMC free article] [PubMed] [Google Scholar]
  4. Feizi T. Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature. 1985 Mar 7;314(6006):53–57. doi: 10.1038/314053a0. [DOI] [PubMed] [Google Scholar]
  5. Fox N., Damjanov I., Knowles B. B., Solter D. Immunohistochemical localization of the mouse stage-specific embryonic antigen 1 in human tissues and tumors. Cancer Res. 1983 Feb;43(2):669–678. [PubMed] [Google Scholar]
  6. Fukuda M. N., Bothner B., Lloyd K. O., Rettig W. J., Tiller P. R., Dell A. Structures of glycosphingolipids isolated from human embryonal carcinoma cells. The presence of mono- and disialosyl glycolipids with blood group type 1 sequence. J Biol Chem. 1986 Apr 15;261(11):5145–5153. [PubMed] [Google Scholar]
  7. Garin-Chesa P., Beresford H. R., Carrato-Mena A., Oettgen H. F., Old L. J., Melamed M. R., Rettig W. J. Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems. Am J Pathol. 1989 Feb;134(2):295–303. [PMC free article] [PubMed] [Google Scholar]
  8. Hakomori S., Kannagi R. Glycosphingolipids as tumor-associated and differentiation markers. J Natl Cancer Inst. 1983 Aug;71(2):231–251. [PubMed] [Google Scholar]
  9. Hsu S. M., Huang L. C., Hsu P. L., Ge Z. H., Ho Y. S., Cuttita F., Mulshine J. Biochemical and ultrastructural study of Leu M1 antigen in Reed-Sternberg cells: comparison with granulocytes and interdigitating reticulum cells. J Natl Cancer Inst. 1986 Aug;77(2):363–370. [PubMed] [Google Scholar]
  10. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  11. Lloyd K. O. Philip Levine award lecture. Blood group antigens as markers for normal differentiation and malignant change in human tissues. Am J Clin Pathol. 1987 Jan;87(1):129–139. doi: 10.1093/ajcp/87.1.129. [DOI] [PubMed] [Google Scholar]
  12. Magnani J. L. Mouse and rat monoclonal antibodies directed against carbohydrates. Methods Enzymol. 1987;138:484–491. doi: 10.1016/0076-6879(87)38041-3. [DOI] [PubMed] [Google Scholar]
  13. Pukel C. S., Lloyd K. O., Travassos L. R., Dippold W. G., Oettgen H. F., Old L. J. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J Exp Med. 1982 Apr 1;155(4):1133–1147. doi: 10.1084/jem.155.4.1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rettig W. J., Cordon-Cardo C., Ng J. S., Oettgen H. F., Old L. J., Lloyd K. O. High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res. 1985 Feb;45(2):815–821. [PubMed] [Google Scholar]
  15. Rettig W. J., Old L. J. Immunogenetics of human cell surface differentiation. Annu Rev Immunol. 1989;7:481–511. doi: 10.1146/annurev.iy.07.040189.002405. [DOI] [PubMed] [Google Scholar]
  16. Sakamoto J., Furukawa K., Cordon-Cardo C., Yin B. W., Rettig W. J., Oettgen H. F., Old L. J., Lloyd K. O. Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res. 1986 Mar;46(3):1553–1561. [PubMed] [Google Scholar]
  17. Santamaria M., Llamas L., Ree H. J., Sheibani K., Ho Y. S., Su I. J., Hsu S. M. Expression of sialylated Leu-M1 antigen in histiocytosis X. Am J Clin Pathol. 1988 Feb;89(2):211–216. doi: 10.1093/ajcp/89.2.211. [DOI] [PubMed] [Google Scholar]
  18. Schuller-Petrovic S., Gebhart W., Lassmann H., Rumpold H., Kraft D. A shared antigenic determinant between natural killer cells and nervous tissue. Nature. 1983 Nov 10;306(5939):179–181. doi: 10.1038/306179a0. [DOI] [PubMed] [Google Scholar]
  19. Sheibani K., Battifora H., Burke J. S., Rappaport H. Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases. Am J Surg Pathol. 1986 Apr;10(4):227–236. doi: 10.1097/00000478-198604000-00001. [DOI] [PubMed] [Google Scholar]
  20. Shevinsky L. H., Knowles B. B., Damjanov I., Solter D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell. 1982 Oct;30(3):697–705. doi: 10.1016/0092-8674(82)90274-4. [DOI] [PubMed] [Google Scholar]
  21. Solter D., Knowles B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A. 1978 Nov;75(11):5565–5569. doi: 10.1073/pnas.75.11.5565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Williams L. K., Sullivan A., McIlhinney R. A., Neville A. M. A monoclonal antibody marker of human primitive endoderm. Int J Cancer. 1982 Dec 15;30(6):731–738. doi: 10.1002/ijc.2910300609. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES